Skip to main content
EMN
NYSE Industrial Applications And Services

Eastman Chemical Reports Steep Q1 Earnings Decline, Amends Credit Facility Covenant Amid Weak Market

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
8
Price
$76.15
Mkt Cap
$8.708B
52W Low
$56.11
52W High
$84.18
Market data snapshot near publication time

summarizeSummary

Eastman Chemical reported a substantial 41% drop in Q1 net earnings and EPS, alongside a 5% revenue decline. The company also amended its credit facility to temporarily adjust a key leverage covenant, indicating ongoing financial pressures.


check_boxKey Events

  • Significant Earnings and EPS Decline

    Net earnings attributable to Eastman fell 41.2% to $107 million ($0.93 diluted EPS) in Q1 2026, compared to $182 million ($1.57 diluted EPS) in Q1 2025.

  • Revenue Decrease

    Sales revenue decreased by 5% to $2,177 million in Q1 2026 from $2,290 million in Q1 2025, driven by lower sales volume and selling prices, partially offset by favorable foreign currency exchange.

  • Credit Facility Covenant Adjustment

    The company amended its $1.50 billion revolving credit agreement to extend its maturity to February 2031 and temporarily adjust the maximum leverage ratio covenant through June 30, 2027, citing potential macroeconomic uncertainty.

  • Increased Borrowings and Net Debt

    Total borrowings increased by $433 million to $5,220 million, and net debt rose by $334 million to $4,555 million as of March 31, 2026, following the issuance of $600 million in new notes and repayment of a $150 million term loan.


auto_awesomeAnalysis

Eastman Chemical Company reported a significant year-over-year decline in its first-quarter 2026 financial performance, with net earnings and diluted EPS both falling over 40%. This continues a negative trend from 2025. The company's revenue also decreased by 5% due to lower sales volume and pricing. A notable concern is the amendment to its $1.50 billion revolving credit facility, which includes a temporary adjustment to the maximum leverage ratio covenant through June 30, 2027, signaling management's proactive response to potential macroeconomic uncertainty impacting operating results. While a $22 million IEEPA tariff refund provided a partial offset to cost of sales, and cash used in operating activities improved, the overall financial picture for the quarter is challenging, marked by increased total and net debt. Investors should monitor the company's ability to improve profitability and manage its leverage in the coming quarters.

At the time of this filing, EMN was trading at $76.15 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $56.11 to $84.18. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EMN - Latest Insights

EMN
May 12, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
EMN
May 01, 2026, 11:58 AM EDT
Filing Type: 10-Q
Importance Score:
8
EMN
Apr 30, 2026, 4:18 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
EMN
Mar 24, 2026, 4:03 PM EDT
Filing Type: DEF 14A
Importance Score:
8
EMN
Feb 20, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
EMN
Feb 17, 2026, 4:10 PM EST
Filing Type: FWP
Importance Score:
8
EMN
Feb 13, 2026, 11:58 AM EST
Filing Type: 10-K
Importance Score:
8
EMN
Jan 29, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8